Stay updated on Effect of Oral AT1001 in Fabry Disease Clinical Trial
Sign up to get notified when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.

Latest updates to the Effect of Oral AT1001 in Fabry Disease Clinical Trial page
- Check3 days agoChange DetectedThe footer now shows Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check18 days agoChange DetectedThe update is a minor site version change from v3.4.0 to v3.4.1; no study data, endpoints, or locations appear to have changed.SummaryDifference0.0%

- Check32 days agoChange DetectedShow glossary feature added. Metadata updates include capitalization tweaks for QC criteria and No FEAR Act data, and the revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a comprehensive Locations section listing participating sites across multiple states and Quebec and updated the page revision to v3.3.3.SummaryDifference1%

- Check89 days agoChange DetectedThe page shows a version update from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Effect of Oral AT1001 in Fabry Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Oral AT1001 in Fabry Disease Clinical Trial page.